OKYO Pharma (OKYO) continues to leapfrog through the development stages for its game changing dry eye disease treatment, OK-101.
OKYO Pharma (OKYO) continues to leapfrog through the development stages for its game changing dry eye disease treatment, OK-101.
There were more booms than Basil Brush for podcaster Audioboom (BOOM) on media reports of interest from both Amazon and Spotify over the weekend.
Canadian Overseas Petroleum (COPL), an international oil and gas exploration, production and development company, announced “in market” share purchases by Arthur Millholland, President and CEO.
After yesterday’s RNS from OKYO Pharma (OKYO), a biotechnology company, there was some leading from the front by Gabriele Cerrone, the Executive Chairman. He purchased 200,000 ordinary shares 5p and
Microsaic (MSYS) announced the addition of a new technology capability to its platform. This latest addition to the platform is expected to launch in H1 2022.
High growth FinTech and De-Fi group Dispersion (DEFI) started the week backed by a research note from broker Tennyson Securities. Tennyson said that through its two client-facing brands,
COP26 has a blind spot. The prime ministers and corporate bigwigs gathered in Glasgow want to cut demand for the fossil fuels that constitute most of the world’s greenhouse gas emissions. To
Oracle Power (ORCP), the AIM quoted natural resources and power project developer, unveiled an updated presentation on its Western Australian gold assets.
Celebrations are in order at Omega (ODX), the specialist medical diagnostics company as it announces that it has signed a partnership agreement with DAM Health Limited, one of the UK’s
There were a couple of overnight broker notes and targets to chew on amongst a couple of the more high profile private investor stocks.
The latest from Xtract Resources (XTR) takes us away from Bushranger as it announced the preliminary unaudited results for alluvial mining contractors for the Manica Concession for the three-month period
Eurasia Mining PLC (EUA.L) Placement of US$15m at 26p for Rosgeo JV, announced that it has entered into a securities purchase agreement for a private placement. The cash position of